Log In
BCIQ
Print this Print this
 

Vesicare OD, solifenacin succinate

  Manage Alerts
Collapse Summary General Information
Company Astellas Pharma Inc.
DescriptionOrally disintegrating tablet formulation of Vesicare, a muscarinic receptor antagonist
Molecular Target Muscarinic receptor
Mechanism of ActionMuscarinic receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationIncontinence
Indication DetailsTreat overactive bladder (OAB)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today